Preview

Safety and Risk of Pharmacotherapy

Advanced search

Adverse Events Following Vaccination: A Review of Russian and International Terminology

https://doi.org/10.30895/2312-7821-2024-12-1-14-23

Abstract

SCIENTIFIC RELEVANCE. Inconsistent terminology for vaccine safety may create challenges for healthcare professionals in identifying, interpreting, and assessing adverse events following vaccination in clinical practice.

AIM. The authors aimed to review Russian and international terminology for adverse events following vaccination.

DISCUSSION. This review covers the terminology used in Russian, EAEU, WHO, and ICH documents. The term “adverse event” is used in most Russian and international pharmacovigilance regulations and guidelines; this term universally defines undesirable consequences associated with medicinal products regardless of their therapeutic class. Russian regulations and guidelines use various terms to describe adverse events following vaccination, including “adverse events”, “side effects of vaccines”, and “post-vaccination complications”. In 2019, the Ministry of Health of Russia approved the Guidelines for the Detection, Investigation, and Prevention of Side Effects Following Immunisation. However, the term “side effects following immunisation” cannot unambiguously characterise the safety of vaccines, as this term can refer to negative, neutral, or positive events following vaccination. The term “post-vaccination complications” is defined in Russian legislation as a list of pathological conditions. The list is not exhaustive and does not fully reflect the definition of post-vaccination complications as severe and/or persistent health issues following vaccination. The term “adverse events following immunisation”, which is recommended by most international guidelines, describes the negative consequences of vaccination more accurately. At the same time, the term “post-vaccination complications” can be reformulated as “serious adverse events following vaccination” with clearly defined and categorised criteria.

CONCLUSIONS. In addition to aiding in detecting, classifying, and evaluating adverse events following immunisation, the unification of terminology for vaccine safety in Russian regulations and guidelines will also facilitate risk mitigation in both individual and mass vaccination campaigns in general.

About the Authors

A. S. Korovkin
Scientific Centre for Expert Evaluation of Medicinal Products
Russian Federation

Alexey S. Korovkin, Cand. Sci. (Med.).

8/2 Petrovsky Blvd, Moscow 127051



D. V. Gorenkov
Scientific Centre for Expert Evaluation of Medicinal Products
Russian Federation

Dmitry V. Gorenkov

8/2 Petrovsky Blvd, Moscow 127051



References

1. Borisevich IV, Supotnitsky MV. Farewell to Tarasevich State Control Institute... BIOpreparations. Prevention, Diagnosis, Treatment. 2011;(3):6-15 (In Russ.). EDN: RENCWL

2. Tatochenko VK, Bakradze MD. Pneumococcal infection- underestimated danger for children health. Children Infections. 2008;7(2):36-40 (In Russ.). EDN: lUJOXZ

3. Voss EA, Shoaibi A, Yin Hui Lai L, Blacketer C, Alsham- mari T, Makadia R, et al. Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study. eClin- icalMedicine. 2023;58:101932. https://doi.org/10.1016/j.eclinm.2023.101932

4. Fraiman J, Erviti J, Jones M, Greenland S, Whelan P, Kaplan RM, Doshi P. Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults. Vaccine. 2022;40(40):5798-805. https://doi.org/10.1016/j.vaccine.2022.08.036

5. Das MK. Adverse events following immunization - the known unknowns and black box: based on 10th Dr. I.C. Verma excellence award for young pediatricians delivered as oration on 9th Oct. 2022. Indian J Pediatr. 2023;90(8):817-25. https://doi.org/10.1007/s12098-023-04555-3

6. Gartlan C, Tipton T, Salguero FJ, Sattentau 0, Gorrin- ge A, Carroll MW. Vaccine-associated enhanced disease and pathogenic human coronaviruses. Front Immunol. 2022;13:882972. https://doi.org/10.3389/fimmu.2022.882972

7. Zhang A, Stacey HD, Mullarkey CE, Miller MS. Original antigenic sin: how first exposure shapes lifelong anti-influenza virus immune responses. J Immunol. 2019;202(2):335-40. https://doi.org/10.4049/jimmunol.1801149

8. Fitzpatrick M. The Cutter incident: how America's first polio vaccine led to a growing vaccine crisis. J R Soc Med. 2006;99(3):156. https://doi.org/10.1177/014107680609900320

9. Tereshkina NV, Snegireva II, Darmostukova MA. Possible causes of and measures to minimise risks of abscesses following DTP vaccination. Safety and Risk of Pharmacotherapy. 2021;9(1):3-14 (In Russ.). https://doi.org/10.30895/2312-7821-2021-9-1-3-14

10. Bernard DM, Cooper Robbins SC, McCaffery KJ, Scott CM, Skinner SR. The domino effect: adolescent girls' response to human papillomavirus vaccination. Med J Aust. 2011;194(6):297-300. https://doi.org/10.5694/j.1326-5377.2011.tb02978.x

11. Neha R, Subeesh V, Beulah E, Gouri N, Maheswari E. Postlicensure surveillance of human papillomavirus vaccine using the Vaccine Adverse Event Reporting System, 2006-2017. Perspect Clin Res. 2020;11(1):24-30. https://doi.org/10.4103/picr.PICR 140 18

12. Hawken S, Ducharme R, Rosella LC, Benchimol EI, Langley JM, Wilson K, et al. Assessing the risk of intussusception and rotavirus vaccine safety in Canada. Hum Vaccin Immunother. 2017;13(3):703-10. https://doi.org/10.1080/21645515.2016.1240846

13. Gidengil C, Goetz MB, Newberry S, Maglione M, Hall O, Larkin J, et al. Safety of vaccines used for routine immunization in the United States: an updated systematic review and meta-analysis. Vaccine. 2021;39(28):3696-716. https://doi.org/10.1016/j.vaccine.2021.03.079

14. Arlegui H, Nachbaur G, Praet N, Begaud B. Quantitative benefit-risk models used for rotavirus vaccination: a systematic review. Open Forum Infect Dis. 2020;7(4):ofaa087. https://doi.org/10.1093/ofid/ofaa087

15. Vazquez M. Safety of second-generation rotavirus vaccines, intussusception. Curr Opin Pediatr. 2014;26(1):101-5. https://doi.org/10.1097/MOP.0000000000000051

16. Burke RM, Tate JE, Kirkwood CD, Steele AD, Parashar UD. Current and new rotavirus vaccines. Curr Opin Infect Dis. 2019;32(5):435-44. https://doi.org/10.1097/QCO.0000000000000572

17. Godlee F, Smith J, Marcovitch H. Wakefield's article linking MMR vaccine and autism was fraudulent. BMJ. 20n;342:c7452. https://doi.org/10.1136/bmj.c7452

18. Hviid A, Hansen JV, Frisch M, Melbye M. Measles, mumps, rubella vaccination and autism: a nationwide cohort study. Ann Intern Med. 2019;170(8):513-20. https://doi.org/10.7326/M18-2101

19. Taylor LE, Swerdfeger AL, Eslick GD. Vaccines are not associated with autism: an evidence-based meta-analysis of case-control and cohort studies. Vaccine. 2014;32(29):3623-9. https://doi.org/10.1016/j.vaccine.2014.04.085

20. Di Pietrantonj C, Rivetti A, Marchione P, Debalini MG, Demicheli V. Vaccines for measles, mumps, rubella, and varicella in children. Cochrane Database Syst Rev. 2020;4(4):CD004407. https://doi.org/10.1002/14651858.CD004407.pub4

21. Mohammed SA, Rajashekar S, Giri Ravindran S, Kakarla M, Ausaja Gambo M, Yousri Salama M, et al. Does vaccination increase the risk of autism spectrum disorder? Cureus. 2022;14(8):e27921. https://doi.org/10.7759/cureus.27921

22. DeStefano F, Shimabukuro TT. The MMR vaccine and autism. Annu Rev Virol. 2019;6(1):585-600. https://doi.org/10.1146/annurev-virology-092818-015515

23. Shamsheva OV. Post-vaccination reactions and methods of their prevention. Pediatric Practice. 2011;(3):46-50 (In Russ.). EDN: TWGPJD

24. Kharit SM, Lakotkina EA, Chernyaeva TV, Voronina OL, Nacharova EP. Differential diagnosis of post-vaccination complications. Difficult Patient. 2006;2(1):17-22 (In Russ.). EDN: ODSWHP

25. Bakhmutskaya EV, Chernyavskaya OP, Volkova NA. Monitoring system for adverse events following immunization in Russia and the world. Modern aspects and problems. Epidemiology and Vaccinal Prevention. 2022;21(5):4-13 (In Russ.). https://doi.org/10.31631/2073-3046-2022-21-5-4-13

26. Nacharova EP, Kharit SM, Lobzin YuV, Briko NI. Principles of monitoring of adverse events after vaccination in Russian Federation and the world. Journal of Microbiology, Epidemiology and Immunobiology. 2017;(1):86-96 (In Russ.). https://doi.org/10.36233/0372-9311-2017-1-86-96

27. Moiseeva IE. Vaccination in the practice of a family doctor. Russian Family Doctor. 2010;14(2):4-15 (In Russ.). EDN:NCRCUF

28. Kaplina SP, Kharit SM, Skripchenko NV. Preventive vaccination in Russia under current conditions. Russian Bulletin of Perinatology and Pediatrics. 2018;63(1):5-13 (In Russ.). https://doi.org/10.21508/1027-4065-2018-63-1-5-13


Supplementary files

Review

For citations:


Korovkin A.S., Gorenkov D.V. Adverse Events Following Vaccination: A Review of Russian and International Terminology. Safety and Risk of Pharmacotherapy. 2024;12(1):14-23. (In Russ.) https://doi.org/10.30895/2312-7821-2024-12-1-14-23

Views: 3801


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2312-7821 (Print)
ISSN 2619-1164 (Online)